89088-56-2

Basic information

• Product Name: METHYL-3-AMINO-1-METHYL PYRAZOLE-5-CARBOXYLATE
• Synonyms: METHYL-3-AMINO-1-METHYL PYRAZOLE-5-CARBOXYLATE;Methyl 3-aMino-1-Methyl-1H-pyrazole-5-carboxylate;Methyl 5-amino-2-methyl-pyrazole-3-carboxylate
• CAS NO: 89088-56-2
• Molecular Formula: C₆H₉N₃O₂
• Molecular Weight: 155.15
• Mol File: 89088-56-2.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 326.168 °C at 760 mmHg
• Flash Point: 151.062 °C
• Appearance: /
• Density: 1.351 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.584
• CAS DataBase Reference: METHYL-3-AMINO-1-METHYL PYRAZOLE-5-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL-3-AMINO-1-METHYL PYRAZOLE-5-CARBOXYLATE(89088-56-2)
• EPA Substance Registry System: METHYL-3-AMINO-1-METHYL PYRAZOLE-5-CARBOXYLATE(89088-56-2)

Safety Data

• Hazardous Substances Data: 89088-56-2(Hazardous Substances Data)

Usage

General Description

"METHYL-3-AMINO-1-METHYL PYRAZOLE-5-CARBOXYLATE" is a chemical compound with the molecular formula C7H10N4O2. It is commonly used as a chemical intermediate in the synthesis of pharmaceuticals and agrochemicals. METHYL-3-AMINO-1-METHYL PYRAZOLE-5-CARBOXYLATE is a derivative of pyrazole and contains an amino group, a carboxylic ester group, and a methyl group. It is known for its potential biological activities and has been studied for its potential use in drug development. Its structure and properties make it a versatile building block for the synthesis of various organic compounds.

InChI:InChI=1/C6H9N3O2/c1-9-4(6(10)11-2)3-5(7)8-9/h3H,1-2H3,(H2,7,8)

Upstream product

• 117860-58-9 methyl 3-<(benzyloxycarbonyl)amino>-1-methylpyrazole-5-carboxylate 
• 89088-54-0 5-carbomethoxy-3-(2,5-dimethylpyrrolyl)-1-methylpyrazole 
• 33146-99-5 methyl ester of 1-methylpyrazole-3,5-dicarboxylic acid 
• 117860-56-7 5-(methoxycarbonyl)-1-methyl-1H-pyrazole-3-carboxylic acid 
• 232281-29-7 1-methyl-5-methoxycarbonylpyrazole-3-carbonyl chloride 
• 1029512-15-9 5-Azidocarbonyl-2-methyl-2H-pyrazole-3-carboxylic acid methyl ester 
• 796038-07-8 1-methyl-5-nitro-1H-pyrazole-3-carboxylic acid methyl ester 
• 177409-38-0 2-methyl-5-nitro-2H-pyrazole-3-carboxylic acid methyl ester 
• 181585-93-3 5-nitro-2H-pyrazole-3-carboxylic acid methyl ester 

Downstream Products

• 117860-58-9 methyl 3-<(benzyloxycarbonyl)amino>-1-methylpyrazole-5-carboxylate 
• 177409-16-4 1-methyl-4-<4-bis(2-chloroethyl)aminophenylamido>pyrazole-5-carboxylic acid 
• 177409-15-3 methyl 1-methyl-4-<4-bis(2-chloroethyl)aminophenylamido>pyrazole-5-carboxylate 
• 245467-36-1 3-(acetylamino)-1-methylpyrazole-5-carboxylic acid 
• 223437-71-6 methyl 3-<1-methyl-3-<1-methyl-3-<1-methyl-3-<4-bis(2-chloroethyl)aminophenylamido>-pyrazole-5-carboxamido>pyrazole-5-carboxamido>>pyrazole-5-carboxylate 
• 223437-72-7 3-<1-methyl-3-<1-methyl-3-<1-methyl-3-<4-bis(2-chloroethyl)aminophenylamido>-pyrazole-5-carboxamido>pyrazole-5-carboxamido>>pyrazole-5-carboxylic acid 
• 223437-73-8 N-succinimidyl-<1-methyl-3-<1-methyl-3-<1-methyl-3-<4-bis(2-chloroethyl)aminophenylamido>-pyrazole-5-carboxamido>pyrazole-5-carboxamido>>pyrazole-5-carboxylate 
• 177409-38-0 2-methyl-5-nitro-2H-pyrazole-3-carboxylic acid methyl ester 
• 177409-39-1 1-methyl-3-nitro-1H-pyrazole-5-carboxylic acid 
• 1346669-68-8 5-[2-(hydroxymethyl)-3-(5-{[5-(2-hydroxypropan-2-yl)-1-methyl-1H-pyrazol-3-yl]amino}-1-methyl-6-oxo-1,6-dihydropyridazin-3-yl)phenyl]-8-thia-5-azatricyclo[7.4.0.0(2,7)]trideca-1⁽⁹⁾,2⁽⁷⁾-dien-6-one 
• 10250-64-3 2-Methyl-5-phenyl-2H-pyrazole-3-carboxylic acid 

Relevant articles and documents

FUSED RING PYRIMIDONE DERIVATIVES FOR USE IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES

Provided are compounds according to any of Formula (I-1) to (I-7), pharmaceutical compositions comprising at least one of said compounds, their use as a medicament, and their use in treating chronic hepatitis B virus (HBV) infection. Methods for preparing compounds according to any of Formula (I-1) to (I-7) are also provided.

SULPHONAMIDES AND COMPOSITIONS THEREOF FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: wherein the variables shown in Formula AA can be as defined anywhere herein. Compounds AA are modulators of NLRP1 and/or NLRP3

PYRIDAZINONE GLUCOKINASE ACTIVATORS

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.